Physician profile
Nathan E Nachlas
NPI 1497737647
$5,127.49
in general payments reported to CMS, 2019-2025
25 companies · $535 in 2025
The $535 reported for 2025 was more than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,412 · 2020: $460 · 2021: $616 · 2022: $551 · 2023: $506 · 2024: $1,047 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,089.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $899.93 | 2019-2023 | Acclarent Navwire, Acclarent Aera, Relieva Spinplus |
| Optinose US, INC. | $699.43 | 2019-2025 | |
| Inspire Medical Systems, INC. | $479.08 | 2024-2025 | Inspire |
| Aerin Medical INC. | $473.98 | 2019-2020 | |
| Intersect Ent, INC. | $473.48 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $341.18 | 2019-2025 | Dupixent |
| Genzyme Corporation | $294.05 | 2019-2025 | |
| Stryker Corporation | $290.96 | 2019-2025 | Clarifix Cryotherapy Device, Xpress Loprofile, Scopis Ent |
| Glaxosmithkline, LLC. | $225.47 | 2020-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $158.18 | 2019-2022 | |
| Livanova USA, INC. | $144.82 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Smith+Nephew, INC. | $113.59 | 2019-2020 | |
| Alk-Abello, INC | $107.40 | 2019-2022 | |
| Itamar Medical INC | $85.39 | 2022-2023 | Watchpatone |
| Ars Pharmaceuticals Operations, INC. | $73.60 | 2025 | Neffy |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $69.65 | 2019-2023 | Auvi-Q |
| Xoran Technologies LLC | $51.21 | 2020 | |
| Genentech, INC. | $47.95 | 2020 | |
| Integra Lifesciences Corporation | $37.32 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Intra-Sana Laboratories | $24.85 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Allergan, INC. | $19.53 | 2021 | |
| Photonicare INC | $16.44 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Nachlas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.